SPONSOR
The First Affiliated Hospital of Soochow University
Total Trials
11
Recruiting
11
Phases
Phase 1, Phase 2, Phase 2, Phase 1
Conditions studied: Multiple MyelomaB Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeMarginal Zone Lymphoma (MZL)NutritionHematopoietic Stem Cell TransplantationIrritable Bowel SyndromeIrritable Bowel Syndrome With Diarrhea (IBS-D)Repetitive Transcranial Magnetic Stimulation (rTMS)ProbioticChronic Diarrhea
The First Affiliated Hospital of Soochow University is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Multiple Myeloma, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Marginal Zone Lymphoma (MZL), Nutrition.
The trial portfolio spans Phase 1, Phase 2, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The First Affiliated Hospital of Soochow University
How many clinical trials has The First Affiliated Hospital of Soochow University sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by The First Affiliated Hospital of Soochow University, of which 11 are actively recruiting participants. These trials cover conditions including Multiple Myeloma, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Marginal Zone Lymphoma (MZL). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The First Affiliated Hospital of Soochow University research focus on?
The First Affiliated Hospital of Soochow University clinical trials span Multiple Myeloma, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Marginal Zone Lymphoma (MZL), Nutrition, Hematopoietic Stem Cell Transplantation, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The First Affiliated Hospital of Soochow University clinical trial?
To participate in a The First Affiliated Hospital of Soochow University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The First Affiliated Hospital of Soochow University trials with current recruitment status updated daily.
Clinical Trials by The First Affiliated Hospital of Soochow University
NCT03196414 Phase 1, Phase 2
Recruiting
Study of T Cells Targeting CD138/BCMA/CD19/More Antigens (CART-138/BCMA/19/More) for Chemotherapy Refractory and Relapsed Multiple Myeloma
Multiple Myeloma
NCT07564453 Phase 2
Recruiting
Full-course Immunotherapy Combined With Chemotherapy in Newly Diagnosed B-cell Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
NCT07372365 Phase 2
Recruiting
Orelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naïve MZL.
Marginal Zone Lymphoma (MZL)
NCT04146870
Recruiting
Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation
Nutrition
NCT06960369 Phase 1
Recruiting
Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Irritable Bowel Syndrome
NCT05657652
Recruiting
CAV Regimen for R/R Ph- B-ALL
Acute Lymphoblastic Leukemia
NCT07647263 Phase 2
Recruiting
Trastuzumab Rezetecan Neoadjuvant Therapy in THP-Insensitive HER2-Positive Early Breast Cancer
HER2-positive Breast Cancer
NCT06682416
Recruiting
The Impact of Local Anesthetic Solution Temperature on Epidural-related Maternal Fever
Epidural Related Maternal Fever
NCT04660487
Recruiting
Relationship Between "FODMAPs" and "GVHD"
Graft Versus Host Disease
NCT07059741
Recruiting
Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL
Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)
NCT07672262 Phase 2
Recruiting
VA Consolidation in Intermediate-Risk AML
Acute Myeloid Leukemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology